Pomiferin Induces Antiproliferative and Pro-Death Effects in High-Risk Neuroblastoma Cells by Modulating Multiple Cell Death Pathways
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083600 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Manu Gnanamony und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Illinois College of Medicine Peoria, One Illini Drive, Peoria, IL 61605, USA. Hauptthemen laut MEDLINE: Neuroblastoma, Cell Proliferation, Isoflavones. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: William E. McElroy Foundation, Children's Hospital of Illinois, U.S. Department of Agriculture, Agricultural Research Service.
Abstract (Originalsprache)
Resistance to chemotherapy-induced apoptosis significantly hinders the successful treatment of high-risk neuroblastoma (NB). Natural compounds, such as osajin and pomiferin—isoflavones extracted from Osage orange (Maclura pomifera [Raf.] Schneid.)—have known anti-inflammatory and anticancer properties and may have the potential as a therapeutic agent to target conventional drug resistance in NB. In this study, we investigated the antiproliferative and cytotoxic potential of osajin and pomiferin in NB cell lines. Both compounds reduced proliferation and induced cytotoxicity, with pomiferin showing a lower IC50 than osajin. Using multiple techniques, we show that pomiferin induced a dose-dependent increase in apoptosis. In addition to apoptosis, we identified the activation of multiple cell death pathways. Pomiferin induced ferroptosis by inhibiting GPX4 and increasing lipid peroxidation. In addition, pomiferin treatment significantly impaired autophagic machinery. LAN5, a MYCN-amplified cell line, showed increased gasdermin E cleavage in response to pomiferin, suggesting pyroptosis. No changes were observed in phosphorylated MLKL, indicating the absence of necroptosis. In conclusion, our comprehensive evaluation demonstrates that pomiferin activates multiple cell death pathways in high-risk NB cells, potentially offering a valuable strategy to overcome drug resistance to conventional chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Illinois College of Medicine Peoria, One Illini Drive, Peoria, IL 61605, USA.
- Functional Foods Research Unit, United States Department of Agriculture, Agricultural Research Service, National Center for Agricultural Utilization Research, Peoria, IL 61604, USA.
ORCID-Profile: Manu Gnanamony, Pedro A de Alarcon
Förderung
- William E. McElroy Foundation
- Children's Hospital of Illinois
- U.S. Department of Agriculture, Agricultural Research Service
- Owens-OSF Professorship
- Children′s Hospital of Illinois (CHOI)
Zitieren
APA
Gnanamony, M., Thomas, M., Nguyen, T. H., Brownstein, K., & de Alarcon, P. A. (2025). Pomiferin Induces Antiproliferative and Pro-Death Effects in High-Risk Neuroblastoma Cells by Modulating Multiple Cell Death Pathways. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083600
Vancouver
Gnanamony M, Thomas M, Nguyen TH, Brownstein K, de Alarcon PA. Pomiferin Induces Antiproliferative and Pro-Death Effects in High-Risk Neuroblastoma Cells by Modulating Multiple Cell Death Pathways. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083600
BibTeX
@article{Gnanamony2025,
author = {Gnanamony, Manu and Thomas, Maria and Nguyen, Thu Hien and Brownstein, Korey and de Alarcon, Pedro A},
title = {Pomiferin Induces Antiproliferative and Pro-Death Effects in High-Risk Neuroblastoma Cells by Modulating Multiple Cell Death Pathways},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083600}
}
EUVIMED